You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨神州細胞大幅高開近7% 披露新冠疫苗臨牀試驗III期研究進展
格隆匯 11-16 09:28
格隆匯11月16日丨神州細胞大幅高開近7%,報90元,自9月26日見階段低點44.4元以來,股價已經實現翻倍,最新總市值超400億元。神州細胞11月15日晚間披露,控股子公司神州細胞工程自主研發的新冠疫苗SCTV01E和SCTV01C臨牀試驗III期安全性和免疫原性研究與mRNA苗頭對頭比較期中分析取得積極結果。SCTV01C和SCTV01E均達到了預設的終點指標。針對當前流行的奧密克戎BA.1和BA.5變異株真病毒中和抗體滴度兩項主要終點指標,SCTV01E均達到了對比輝瑞mRNA疫苗的統計學意義優效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account